Allogene Therapeutics, Inc. (ALLO)
1.325
0.00 (0.00%)
USD |
NASDAQ |
Oct 21, 16:00
1.325
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Price : 1.325 for Oct. 21, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 1.30 | 1.35 | 1.29 | 1.33 | 4.580M |
| Oct 19, 2026 | 1.30 | 1.33 | 1.26 | 1.30 | 5.906M |
| Oct 16, 2026 | 1.34 | 1.34 | 1.29 | 1.31 | 4.919M |
| Oct 15, 2026 | 1.33 | 1.37 | 1.30 | 1.34 | 4.515M |
| Oct 14, 2026 | 1.28 | 1.308 | 1.22 | 1.30 | 7.737M |
| Oct 13, 2026 | 1.39 | 1.395 | 1.29 | 1.29 | 6.544M |
| Oct 12, 2026 | 1.45 | 1.46 | 1.39 | 1.40 | 4.316M |
| Oct 09, 2026 | 1.39 | 1.48 | 1.370 | 1.46 | 10.61M |
| Oct 08, 2026 | 1.44 | 1.44 | 1.345 | 1.40 | 7.984M |
| Oct 07, 2026 | 1.46 | 1.47 | 1.42 | 1.43 | 3.900M |
| Oct 06, 2026 | 1.50 | 1.50 | 1.43 | 1.46 | 4.660M |
| Oct 05, 2026 | 1.495 | 1.52 | 1.45 | 1.50 | 4.443M |
| Oct 02, 2026 | 1.57 | 1.579 | 1.50 | 1.50 | 4.657M |
| Oct 01, 2026 | 1.60 | 1.61 | 1.53 | 1.54 | 4.607M |
| Sep 30, 2026 | 1.61 | 1.66 | 1.58 | 1.60 | 8.132M |
| Sep 29, 2026 | 1.60 | 1.645 | 1.60 | 1.62 | 4.319M |
| Sep 28, 2026 | 1.65 | 1.665 | 1.60 | 1.63 | 5.026M |
| Sep 25, 2026 | 1.69 | 1.695 | 1.63 | 1.65 | 3.622M |
| Sep 24, 2026 | 1.67 | 1.72 | 1.60 | 1.67 | 7.791M |
| Sep 23, 2026 | 1.73 | 1.74 | 1.65 | 1.67 | 5.966M |
| Sep 22, 2026 | 1.72 | 1.74 | 1.683 | 1.71 | 5.237M |
| Sep 21, 2026 | 1.71 | 1.72 | 1.645 | 1.69 | 5.992M |
| Sep 18, 2026 | 1.73 | 1.74 | 1.67 | 1.69 | 12.72M |
| Sep 17, 2026 | 1.74 | 1.765 | 1.70 | 1.73 | 3.948M |
| Sep 16, 2026 | 1.74 | 1.77 | 1.66 | 1.69 | 5.648M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 58.83 |
| Oncolytics Biotech, Inc. | 0.5142 |
| Sangamo Therapeutics, Inc. | 0.11 |
| Sarepta Therapeutics, Inc. | 18.57 |
| Anixa Biosciences, Inc. | 2.715 |
Price Related Metrics
| PS Ratio | 72.62 |
| Price to Book Value | 1.049 |
| Earnings Yield | -50.20% |
| Market Cap | 457.58M |